Probiotics in prevention and treatment of cardiovascular diseases
Open Access
- 1 December 2021
- journal article
- review article
- Published by Index Copernicus in Herba Polonica
- Vol. 67 (4) , 77-85
Abstract
Increasing knowledge of the gut microbiota and its interference in human homeostasis in recent years has contributed to a better understanding of number of different interactions occurring in the gastrointestinal tract. Disruption of the microbiota is detrimental to health and contributes to the development of numerous diseases and may also be an accelerator of pathophysiological processes such as atherosclerosis. Cardiovascular diseases are the most common cause of death worldwide, so the development of new methods to support the treatment and prevention of these diseases becoms one of the priorities of modern medicine. Probiotics may constitute an important element of support in the treatment and prevention of CVD (cardiovascular diseases). A number of papers support such a statement, however, larger clinical trials are needed. Through a number of mechanisms including mitigating inflammation, sealing the intestinal epithelium, and affecting metabolism, probiotics may have a beneficial effect on general health and slow down the pathogenesis of many diseases, including those affecting the cardiovascular system. This article contains a review of current discoveries on the role of probiotics in the prevention and support of CVD treatment.Keywords
This publication has 68 references indexed in Scilit:
- Insight into the prebiotic concept: lessons from an exploratory, double blind intervention study with inulin-type fructans in obese womenGut, 2012
- Cholesterol-Lowering Probiotics as Potential Biotherapeutics for Metabolic DiseasesExperimental Diabetes Research, 2012
- Effect of the consumption of a new symbiotic shake on glycemia and cholesterol levels in elderly people with type 2 diabetes mellitusLipids in Health and Disease, 2012
- Intestinal microbiota determine severity of myocardial infarction in ratsThe FASEB Journal, 2012
- Relationships between Obesity and Cardiovascular Diseases in Four Southern States and ColoradoJournal Of Health Care For The Poor and Underserved, 2011
- Effects of two Lactobacillus strains on lipid metabolism and intestinal microflora in rats fed a high-cholesterol dietBMC Complementary and Alternative Medicine, 2011
- Gut flora metabolism of phosphatidylcholine promotes cardiovascular diseaseNature, 2011
- Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestineFEMS Microbiology Letters, 2009
- A neutralizing leptin receptor antibody mitigates hypertrophy and hemodynamic dysfunction in the postinfarcted rat heartAmerican Journal of Physiology-Heart and Circulatory Physiology, 2008
- Effects of short chain fatty acids on gut morphology and function.Gut, 1994